Reversible Hypocalcaemic Dilated Cardiomyopathy causing Decompensated Heart Failure- A Case Report
DOI:
https://doi.org/10.5195/ijms.2025.4003Keywords:
Dilated Cardiomyopathy, Hypocalcaemia, Heart Failure, Case ReportsAbstract
Background: Hypocalcaemia induced heart failure, commonly seen in children due to Vitamin D deficiency, is a rare clinical syndrome in adults. These patients are refractory to routine treatment, but the timely diagnosis of the underlying etiology and correction of calcium promptly restores myocardial function.
The Case A 55-year-old non-alcoholic and non-smoker female, previously diagnosed as a case of dilated cardiomyopathy, presented with complaints of progressive dyspnoea on exertion from NYHA-II to NYHA-IV over a span of 1 week. At admission the patient was conscious, afebrile; having respiratory distress, peripheral oxygen saturation of 93% at room air, blood pressure of 92/56 mmHg equal in both arms, regular pulse rate of 100 beats per minute, audible left ventricular S3, mild peripheral edema, and bilateral basal crepitations. She was diagnosed to have decompensated heart failure. Chest X-Ray revealed cardiomegaly. Electrocardiogram showed sinus tachycardia (90 beats/minute), QRS axis of -20o, prolonged QTc of 574 milliseconds. Laboratory analysis at admission revealed minimally deranged liver and renal functions, and highly elevated BNP. Relevant biochemical parameters are shown in the given table. Transthoracic echocardiogram revealed dilated left chambers (left ventricle end-diastolic diameter: 61 mm, left ventricle end-systolic diameter: 52 mm), left ventricle (LV) severe global systolic dysfunction (LVEF=22%) due to diffuse hypokinesia, restrictive type of diastolic dysfunction with elevated filling pressure indexes (E/E’=19), mild functional mitral regurgitation, mild tricuspid regurgitation, moderate pulmonary hypertension (systolic pulmonary artery pressure of 50 mmHg). Normal coronary angiography ruled out underlying ischemia. Patient was initially started on furosemide as decongestive therapy. Subsequent investigations conducted due to prolonged QTc revealed severe hypocalcaemia (corrected calcium of 4.38 mg/dL), inappropriately normal PTH, and presence of basal ganglia calcification on CT head was highly suggestive of primary hypoparathyroidism. Parenteral treatment with Gluconic Calcium was started: 950 mg of calcium (1 ampoule) at 6 hours, followed by oral treatment- high dose of calcium (1g TDS) and alfacalcidol (0.25µg TDS) along with management of heart failure. The patient had progressive clinical improvement and was discharged in NYHA class II on Day 10. Patient’s serum calcium progressively improved during course of stay and was within normal limits at the time of discharge. Treatment at discharge included loop diuretic, ACE inhibitor, Calcium, alfacalcidol. Patient was followed up regularly; and NYHA class, renal functions, serum calcium level, and ECG were assessed. At follow up after 3 months, patients had significant improvement in LV function and normalised LV function after 6 months.
Conclusion: Considering the rarity of hypocalcemia induced dilated cardiomyopathy in adults, this etiology must be suspected in a cardiac patient with ECG changes suggestive of hypocalcaemia (as in our case). Early calcium supplementation, usually along with vitamin D, reduces and even reverses ventricular hypertrophy and dilatation as well as conduction abnormalities, as it was in our case.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Shlok Bhardwaj, Prof. Dr. Bhupinder Singh

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
- Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
- The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
- Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
- The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
- Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
- The Author represents and warrants that:
- the Work is the Author’s original work;
- the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
- the Work is not pending review or under consideration by another publisher;
- the Work has not previously been published;
- the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
- the Work contains no libel, invasion of privacy, or other unlawful matter.
- The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.
Enforcement of copyright
The IJMS takes the protection of copyright very seriously.
If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.
If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to contact@ijms.org
Infringing material
If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to contact@ijms.org


